| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 8 |
| 1 | SERTRALINE | 6 |
| 2 | APIXABAN | 5 |
| 3 | CLOPIDOGREL | 5 |
| 4 | CLOPIDOGREL BISULFATE | 5 |
| 5 | LECANEMAB | 5 |
| 6 | PEMBROLIZUMAB | 4 |
| 7 | PREDNISOLONE | 4 |
| 8 | PREDNISOLONE ORAL | 4 |
| 9 | PREDNISOLONE ORAL SOLUTION | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUTIMLIMAB-JOME | 1 | 0.0031 |
| 1 | ANDEXANET ALFA | 2 | 0.0028 |
| 2 | LECANEMAB | 5 | 0.0013 |
| 3 | PIRTOBRUTINIB | 1 | 0.0010 |
| 4 | LUSPATERCEPT | 2 | 0.0008 |
| 5 | EDOXABAN TOSYLATE | 3 | 0.0004 |
| 6 | OPICAPONE | 1 | 0.0004 |
| 7 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| 8 | PATISIRAN | 1 | 0.0004 |
| 9 | LEMBOREXANT | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 1 | Amyloid Beta-directed Antibody [EPC] | 5 | 0.0013 |
| 2 | Erythroid Maturation Agent [EPC] | 2 | 0.0008 |
| 3 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Orexin Receptor Antagonist [EPC] | 2 | 0.0001 |
| 8 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 9 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |